← Back
Data updated: Jun 28, 2026
US GENERICS, STERILES
Pharma Pharmaceuticals
US GENERICS, STERILES is a pharmaceutical company with 1 FDA-approved products.
-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Upcoming FDA Decisions
Full Calendar → Aug 13, 2026 — LNTH
Oct 17, 2026 — Phentolamine ophthalmic solution 0.75%
US GENERICS, STERILES's Key Drugs
US GENERICS, STERILES's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
US GENERICS, STERILES's Recent FDA Approvals
New NDA/BLA approvals for US GENERICS, STERILES over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
US GENERICS, STERILES's Therapeutic Areas
Disease areas where US GENERICS, STERILES has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
US GENERICS, STERILES Pipeline Snapshot
Active clinical trials for US GENERICS, STERILES across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 1